Generic form of AmBisome®. As a liposomal formulation of Amphotericin B, AmBiL® has effectively reduced toxicities and allowed patients to receive higher and more effective doses.
Indications
Systemic fungal infection
Advantages
AmBiL® is capable of achieving the same safety level as AmBisome® (which is superior than those of other amphotericin B formulations), making AmBiL® the first generic form of AmBisome®